Mylan N.V. | Key People and Executives
Robert J. Coury
Executive Chairman
Rajiv Malik
President & Executive Director
Heather M. Bresch
Chief Executive Officer & Executive Director
Pauline F. M. van der Meer Mohr
Director
Sjoerd Steven Vollebregt
Independent Director
Melina E. Higgins
Independent Non-Executive Director
Randall L. Vanderveen
Independent Non-Executive Director
Mark W. Parrish
Independent Non-Executive Director
Neil F. Dimick
Independent Non-Executive Director
JoEllen Lyons Dillon
Independent Non-Executive Director
Robert J. Cindrich
Independent Non-Executive Director
Robert J. Coury
Executive Chairman
Rajiv Malik
President & Executive Director
Heather M. Bresch
Chief Executive Officer & Executive Director
Haribabu Bodepudi
Chief Operating Officer
Kenneth Scott Parks
Chief Financial Officer
Walt Owens
Head-Global Respiratory & Dermatological Ops
Matthew Erick
Head-North America
Arnd Annweiler
Head-Global R&D
Jose Cotarelo
Head-Japan, Australia & New Zealand
Deb O'Brien
Corporate Brand
Abhijit Barve
Head-Global Clinical Research
Anthony Mauro
Chief Commercial Officer
Jonathan R. Collins
Vice President & Head-eCommerce
Pauline F. M. van der Meer Mohr
Director
Christine Waller
Media Contact
Melissa Trombetta
Head-Global Investor Relations
Dennis Zeleny
Chief Human Relations Officer
Joseph F. Haggerty
Secretary
Daniel M. Gallagher
Chief Legal Officer
Sjoerd Steven Vollebregt
Independent Director
Melina E. Higgins
Independent Non-Executive Director
Randall L. Vanderveen
Independent Non-Executive Director
Mark W. Parrish
Independent Non-Executive Director
Neil F. Dimick
Independent Non-Executive Director
JoEllen Lyons Dillon
Independent Non-Executive Director
Robert J. Cindrich
Independent Non-Executive Director
| Address |
Building 4
Hatfield Hertfordshire AL10 9UL
United Kingdom
|
|
Employees
|
- |
| Website |
http://mylan.co.uk |
| Updated |
07/08/2019 |
| Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other. |
